Irsigler K, Kritz H, Kaspar L, Brändle J, Koller W, Franetzki M
Horm Metab Res Suppl. 1979(8):193-7.
A glucose-controlled insulin infusion system (Biostator) was used to determine patient insulin requirement for clinical evaluation of a portable pump system (technical development by Siemens AG). Results from 6 insulin-dependent diabetics with respect to quality of control, carbohydrate/insulin ratio, and insulin requirement are shown. Preprogrammed insulin infusion with the portable system was carried out for up to 117 days.
使用葡萄糖控制胰岛素输注系统(生物调节器)来确定患者的胰岛素需求量,以便对一种便携式泵系统(由西门子公司进行技术研发)进行临床评估。展示了6名胰岛素依赖型糖尿病患者在控制质量、碳水化合物/胰岛素比率和胰岛素需求量方面的结果。使用便携式系统进行预编程胰岛素输注的时间长达117天。